Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Sümbol: 2196.HK

HKSE

13.28

HKD

Turuhind täna

15.5749
P/E suhe
7.2266
PEG suhe
63.71B
MRK Cap
0.04%
DIV tootlus

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196-HK) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Shanghai Fosun Pharmaceutical (Group) Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	15582.1	17169.8	14549.2	11931.9	9989.9	9162.6	7468.2	6044.5	4062.4	3729.5	3111.6	5197.4	3125.9	3562.3	1308.5	1005.7	1079.6	991.3	752.9	688.1	1242.6	629.4	373.1	343.4	170	329.8	25.3	6.6	7.2
balance-sheet.row.short-term-investments	1888.5	928.5	4241.1	1970.1	456.7	616.1	219.3	48.5	33.8	33.8	44.2	224.8	231.3	218.8	11.7	0.1	5.8	2.1	0	5.2	0.2	285.3	0.9	0	0	0	0	0	0
balance-sheet.row.net-receivables	9967.9	10797.8	9517.7	7256.7	5873.4	5255.7	4522.5	2976.9	2518.7	3318.7	2256.4	1906.4	1797.3	1426.6	925.2	940.2	732.1	811	673.6	618.3	536.6	406.4	545.2	37.5	58.4	31.4	9.1	5.1	26.3
balance-sheet.row.inventory	7537.8	6882.4	5472.3	5162.8	3940.5	3287.4	2750.5	1670.7	1648.8	1604.6	1614.3	1273.4	1123.9	934.4	598	530.5	494.8	607.6	532	472.8	305.1	355.3	120.5	82.8	85	52.3	49.6	18	12.5
balance-sheet.row.other-current-assets	704.8	429.1	885.4	733.4	599.5	296	315.3	72.1	95.5	11.2	4.2	4.3	1.9	14.3	475.2	-59.2	210.6	6.5	3.3	0.5	19	16.1	6	207.7	117	96.6	132.7	77	57.4
balance-sheet.row.total-current-assets	33792.6	35279.2	30424.6	25084.8	20403.4	18001.7	15056.5	10764.3	8325.4	8664	6986.5	8381.5	6049.1	5937.7	3306.9	2417.3	2517.1	2416.4	1961.9	1779.7	2103.4	1407.2	1044.9	671.4	430.5	510.1	216.7	106.7	103.4
balance-sheet.row.property-plant-equipment-net	22239.4	16028.1	13283.9	13002.7	11085.1	9123.1	8315.9	6304.7	5764.9	5681.4	4907.5	3479.7	2627.3	1695.7	1258.8	1145.3	1139.1	1274.4	1240.6	1054	777.2	570.5	349.4	260.6	175.5	74.4	41.6	4.4	3.3
balance-sheet.row.goodwill	10852	10337.1	9400	8677.2	9014	8853.9	8464.3	3473.1	3303.4	3255	2976	1661.8	1585.1	296.4	51.1	51.1	51.1	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	17378.1	15925.3	13433.2	11498.6	10966.2	9192.1	8274.5	3650.6	3245.8	2911.9	2639.4	1782.3	1705.1	533.9	209	200.1	208.4	210.3	197.5	179	114.6	97.9	39.3	48	20.7	0.9	0.5	0	0
balance-sheet.row.goodwill-and-intangible-assets	28230.1	26262.4	22833.1	20175.9	19980.2	18046	16738.8	7123.7	6549.2	6166.9	5615.5	3444	3290.2	830.3	260.1	251.2	259.6	210.3	197.5	179	114.6	97.9	39.3	48	20.7	0.9	0.5	0	0
balance-sheet.row.long-term-investments	23123.8	24620.5	19679	21801.2	22564	23443.5	20904.5	18801.5	17200.5	14371.1	11560.7	9822.5	10011.5	7960.7	6652.3	3683.8	3465.1	2704.8	0	2108.4	1187.1	741.6	760.6	570.3	219.3	46.1	1.7	0	0
balance-sheet.row.tax-assets	624.5	442.6	265.6	244.9	196.1	173.1	144.5	129.6	102.5	101.2	88.1	31.5	16.7	18.4	11.4	12.9	11.8	5.6	0	20.1	36.5	322.4	15.5	-555.5	-211.5	10.6	10.3	0	0
balance-sheet.row.other-non-current-assets	5459.3	4531.2	6807.4	3376.5	1890.9	1763.9	810.8	644	259.3	351.6	316.9	347.9	295.9	377.5	37.6	28.5	42.3	22.3	2268.7	29.4	0	0	-2.4	576.3	223.8	4.9	16.3	0.2	0
balance-sheet.row.total-non-current-assets	79677	71884.7	62869.2	58601.2	55716.3	52549.6	46914.5	33003.5	29876.3	26672.3	22488.6	17125.6	16241.7	10882.5	8220.2	5121.6	4917.9	4217.5	3706.8	3390.8	2115.5	1732.4	1162.4	899.7	427.8	137	70.4	4.6	3.3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	113469.6	107163.9	93293.8	83686	76119.6	70551.4	61971	43767.8	38201.7	35336.3	29475.2	25507.1	22290.8	16820.1	11527.1	7538.9	7435	6633.9	5668.7	5170.5	4218.8	3139.6	2207.3	1571.1	858.2	647.1	287.1	111.3	106.7
balance-sheet.row.account-payables	6159.6	6284	5063.7	3289	2397.3	2333.3	1781.9	1149.4	1048.6	905	1136.4	903.7	939.9	827.3	491.3	398	357.8	530.9	560.3	484	339.3	326.3	89.5	70.5	63.6	36.9	50.8	10.8	5.7
balance-sheet.row.short-term-debt	19555.1	17402.9	14547.6	14911.8	8920.5	10536.8	10478.2	5650.4	7334.2	3950.7	1424.2	875.3	2187.1	1830.4	1583	502.5	1556.4	1465.2	786.3	682	466.3	772.3	627.5	129.7	39.6	0	22.5	29.5	21
balance-sheet.row.tax-payables	537	929.8	727.5	564.7	759.6	478.9	480.1	478.2	503.8	342.9	288.9	162	111.7	247.4	48.9	49.5	73.7	42.1	27.8	38	62.6	61.3	9.5	16.2	8	12.1	10.4	0	-0.1
balance-sheet.row.long-term-debt-total	15554.5	12844.9	9697.4	9103	12987.1	12670.1	9814.9	5571	3571.5	3856.7	4199.7	4280.2	3915.1	2758.3	1284.5	1180.5	746.8	545.1	981.2	752.8	1026.9	45.8	25.2	25.2	13.8	30.1	0.5	0.4	14.3
Deferred Revenue Non Current	639.4	632.4	512.8	482.2	417.3	363.5	397.1	346.7	169.3	139.6	404.5	627.6	374.2	57.8	64.9	65.2	70.1	-449	-877.5	5.1	5.9	-38.8	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	125.2	9611.2	1528.6	54.6	249	4574.3	604.6	944.9	352.8	1337.1	309.5	729.9	221.9	110.6	67.6	541.3	44.1	18.8	40.1	33.6	34.1	32	27	16.4	9.2	37.3	0.6	22.7	34.1
balance-sheet.row.total-non-current-liabilities	23095.8	19756.9	15608.3	12829.4	19481.7	19035.4	15629.1	8408.9	6592.9	6696	6532.6	6309.3	5928.3	3723.4	2076.8	1337.8	900.5	642.4	1087.7	762.7	1035.3	53.9	25.2	27.9	13.8	42.1	0.5	0.4	14.8
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	2049.6	745	648.4	627.3	410.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	56853.3	53055	44918.2	37701.7	36915.4	36958.6	32229.6	18517.5	17532.1	16233.3	11810.7	10202.5	10920	7426.9	4575.1	3093	3118.6	2985.3	2793.7	2356.7	2201.9	1466.2	884.7	352.6	201.1	116.4	154.5	79.3	81.1
balance-sheet.row.preferred-stock	1300.1	1198.4	1265.8	933.6	468	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2672.4	2672.2	2562.9	2562.9	2562.9	2563.1	2495.1	2414.5	2314.1	2311.6	2240.5	2240.5	1904.4	1904.4	1237.8	1237.8	1237.8	952.1	832	826.5	381.9	381.9	293.8	293.8	226.1	150.7	58.8	20	20
balance-sheet.row.retained-earnings	24542.5	23216.9	21039.6	17505	15125.7	12771.5	11111.6	8993.8	6937	5457	7112.7	5703	4483.5	3717.7	3258.2	1184.8	715.1	262.9	349.3	411.3	372.5	182.1	143.4	108.6	114.4	46.8	27.5	6.2	2.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	-1300.1	-1198.4	-1265.8	-933.6	-468	-4436.3	-4000.5	-3047.9	-2592.5	-2164.5	-1671.5	-1213.5	-1061.4	-871.5	-654.1	-544.9	-478	0	-9	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	18469.9	18693.4	15589.5	16927.7	14199.5	17079.5	15720.6	13829.8	11523	11070.7	7650.6	6828.8	4445.4	3672.4	2634.7	2131.2	2397.4	1875.2	1218.6	1066.4	945.8	845.5	826.8	743.2	264.1	321.7	14.4	5.7	2.7
balance-sheet.row.total-stockholders-equity	45684.8	44582.5	39191.9	36995.5	31888.1	27977.7	25326.9	22190.2	18181.6	16674.8	15332.2	13558.8	9771.9	8423	6476.5	4008.9	3872.3	3090.2	2390.9	2304.1	1700.2	1409.5	1264	1145.5	604.5	519.1	100.7	32	25.6
balance-sheet.row.total-liabilities-and-stockholders-equity	113469.6	107163.9	93293.8	83686	76119.6	70551.4	61971	43767.8	38201.7	35336.3	29475.2	25507.1	22290.8	16820.1	11527.1	7538.9	7435	6633.9	5668.7	5170.5	4218.8	3139.6	2207.3	1571.1	858.2	647.1	287.1	111.3	106.7
balance-sheet.row.minority-interest	10931.5	9526.5	9183.6	8988.7	7316.1	5615	4414.6	3060.1	2488.1	2428.2	2332.3	1745.9	1599	970.2	475.5	437.1	444.1	558.3	484.2	509.7	316.7	263.9	58.7	73	52.6	11.6	32	0	0
balance-sheet.row.total-equity	56616.3	54108.9	48375.6	45984.3	39204.2	33592.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	25012.3	25549.1	23920.1	23771.3	23020.6	24059.6	21123.8	18850	17234.2	14404.9	11604.9	10047.3	10242.8	8179.4	6664	3683.9	3471	2706.9	2227.2	2113.6	1187.3	1026.9	760.6	570.3	219.3	46.1	1.7	0	0
balance-sheet.row.total-debt	35109.6	30247.7	24245	24014.8	21907.6	23206.9	20293.1	11221.3	10905.7	7807.4	5623.9	5155.5	6102.1	4588.7	2867.5	1683	2303.2	2010.3	1767.5	1434.8	1493.2	818.1	652.6	154.9	39.6	30.1	22.5	29.5	35.4
balance-sheet.row.net-debt	21416	14006.4	13936.9	14053	12374.4	14660.4	13044.2	5225.3	6877.1	4111.7	2556.5	183	3207.6	1245.2	1570.8	677.3	1229.4	1021.1	1014.6	752	250.8	474	280.4	-188.5	-130.4	-299.7	-2.8	22.9	28.2

Rahavoogude aruanne

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	2895.1	3947.5	4987.4	3940	3743.5	3019.9	3585.3	3221.3	2870.7	2369.8	2399.9	1839.3	1384.8	1000.3	2564.3	760.9	690.2	292.8	237.9	282.1	298.2	161.7	141.1	135.8	94.4	64.9
cash-flows.row.depreciation-and-amortization	2965.2	2335.9	1834.4	1666.2	1472.1	1320.1	938.6	732.9	649.3	558.4	415.5	286.2	209.9	152.7	134.7	132.5	136.5	132.1	116.7	91.1	56.1	37.6	28.6	28.1	20.1	9.3
cash-flows.row.deferred-income-tax	-2723.5	0	-4038.6	-2605.1	-2733	-1876.1	-2322.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	35.9	54.5	64.3	55.2	109.1	72.3	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-1081.2	-1387.9	259.7	-1401.4	-494.6	-535.1	-212.7	-288.1	-101.8	-555.3	-44.5	-28.2	-88.6	11	599.1	13.6	-133.7	-5.4	-107	789.2	23.2	-35	-45.2	0.8	-78	-10.8
cash-flows.row.account-receivables	1605.1	-2076.6	-1795	-1559.9	-863.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-333.9	-1430.1	-464.7	-1253.4	-505.2	-564.7	-491.1	-65.4	-88.3	-105	-149.6	-155.1	-99.8	-66.2	-70.1	-27.6	109.6	-42.7	-67	-27	56	-11.2	-37.5	12.4	-14.4	-4.9
cash-flows.row.account-payables	-1605.1	2076.6	1795	1559.9	863.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-2352.4	42.2	724.5	-148	10.6	29.6	278.4	-222.7	-13.4	-450.3	105.1	126.9	11.2	77.2	669.2	41.2	-243.3	37.2	-40	816.2	-32.8	-23.8	-7.7	-11.6	-63.6	-5.9
cash-flows.row.other-non-cash-items	1322.7	-732.4	841.5	924.9	1125.3	949	580.8	-1556.1	-1797.2	-1172.7	-1759.4	-1431.8	-1189.5	-960.6	-3036.2	-673.9	-561.5	-234.6	-59.3	-957.3	-227.3	-61.8	-56.3	-26.3	1.7	3.2
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-5336.7	-5888.8	-4972.6	-4437.1	-3962.1	-3174.9	-2170.6	-1922	-1235.5	-1119.4	-1040.1	-1160.6	-796.8	-339.2	-348.1	-210.6	-209.7	-266.6	-222.6	-205	-264.1	-139.5	-141.5	-126.6	-78	-52.2
cash-flows.row.acquisitions-net	-923.7	-487.6	381.4	-140.3	-818.8	-622.6	-7822.6	-249.4	109.9	-1145.7	-2225.2	30.8	12.7	2.1	-2.6	22.8	9.3	18.2	279.9	11.6	25.5	4.9	10.8	17.6	1	0
cash-flows.row.purchases-of-investments	-943	-1501.3	-1424.6	-1070.1	-517.9	-2133.4	-2525.7	-1395.7	-2955.3	-1943.2	-364.1	-759.1	-1500.3	-1190.2	-770.2	-563.2	-543.7	-399.3	-349	-665.1	-134.9	-475.3	-317.8	-345.5	-253.5	-46
cash-flows.row.sales-maturities-of-investments	2809.3	4649.5	2168.3	2037.2	4916.2	1243.4	1550.6	1492.6	2127	1515.9	1540.7	1484.7	615.5	1348	755.5	822.8	632.3	329.6	76.6	45.4	535.7	254.8	243.5	30.2	43.4	0.4
cash-flows.row.other-investing-activites	574.8	-835.9	-9.5	-1095.8	210.6	-557.4	464.2	-372.6	83.9	214.2	285.2	-574.4	-97.6	-85	-32.5	-15.6	58	-17	-222.6	33.9	-0.2	204.6	-282	-19.3	48.2	-2
cash-flows.row.net-cash-used-for-investing-activites	-3819.3	-4064	-3857	-4706.2	-172	-5244.9	-10504.1	-2447.1	-1869.9	-2478.3	-1803.5	-978.6	-1766.5	-264.3	-397.8	56.1	-53.7	-335.1	-437.7	-779.2	162.1	-150.5	-487.1	-443.6	-238.9	-99.8
cash-flows.row.debt-repayment	-21146.2	-26280.1	-27391.9	-15707.8	-13942.1	-9995.1	-9085.3	-9956.1	-7239.7	-2559.5	-2417.6	-3795.9	-4042.2	-2081.7	-1071.9	-1410.2	-1753.9	-1221	-817.9	-727.4	-665.6	-1613.8	-716.1	-311.2	-62.8	-52.4
cash-flows.row.common-stock-issued	0	0	0	0	0	4851.4	3017.6	2728.5	116.1	1466.1	30.5	3151.1	0	637.8	18.9	16.1	17.2	0	0	9	951.5	8.4	6.7	437.6	0	372.4
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	14821.2	7694.5	8990.2	4017.4	2105.1	-17.8	0	3083.4	1703.6	1286	2100.3	0	0	873.7	-589.4	1691	1200.8	-48.5	0	-342.4
cash-flows.row.dividends-paid	-2455.2	-2374.4	-1914	-1834.6	-1864.4	-1775.5	-1433.5	-1193.5	-1109.3	-962.7	-804.5	-500.9	-437.3	-297.4	-268.6	-257.9	-237.6	-371.9	-200	-149.2	-94.9	-89.8	-78.2	-14.1	-13.4	-9.7
cash-flows.row.other-financing-activites	22265.1	33083	28474.6	19009.5	13870.5	10056.8	2588.7	2172.7	-206.6	-98.3	154.3	3231.9	5392.5	480.3	18.9	16.1	17.2	1963.6	1165.7	8.5	984.4	24.1	41	402.5	117.1	369.8
cash-flows.row.net-cash-used-provided-by-financing-activities	-1336.2	4428.5	-831.3	1467.1	-1936	3137.5	9908.6	1446	550.7	1863.1	-932.1	2068.4	913	1822.5	401	-349.9	143.1	370.7	147.8	14.6	586.1	19.9	454.2	466.3	41	337.7
cash-flows.row.effect-of-forex-changes-on-cash	73.6	128.3	-134.7	-300.2	-5.1	-18	-172.5	80.5	36.6	8.9	-31.4	-12	-6	-3.8	-0.7	-4.6	-4.8	-1.2	-0.4	0	-0.1	0	0	0.1	0	0
cash-flows.row.net-change-in-cash	-1667.7	4710.3	-874.2	-959.5	1109.4	824.7	1812.3	1189.4	338.4	593.9	-1755.3	1743.4	-542.9	1757.7	264.3	-65.4	216.1	219.3	-102	-559.5	898.3	-28.2	35.3	161.2	-159.7	304.5
cash-flows.row.cash-at-end-of-period	9502.4	11170.1	6450.7	7324.9	8284.4	7175	6350.3	4538	3348.6	3010.2	2416.3	4171.6	2428.2	2971.1	1213.4	949.1	1014.4	800.2	580.9	682.9	1242.4	344.1	372.3	343.4	170	329.8
cash-flows.row.cash-at-beginning-of-period	11170.1	6459.7	7324.9	8284.4	7175	6350.3	4538	3348.6	3010.2	2416.3	4171.6	2428.2	2971.1	1213.4	949.1	1014.4	798.4	580.9	682.9	1242.4	344.1	372.3	337	182.2	329.8	25.3
cash-flows.row.operating-cash-flow	3414.2	4217.6	3948.7	2579.8	3222.4	2950.1	2580.2	2110	1621	1200.2	1011.6	665.5	316.6	203.4	261.9	233	131.5	184.9	188.3	205.1	150.1	102.5	68.2	138.4	38.2	66.6
cash-flows.row.capital-expenditure	-5336.7	-5888.8	-4972.6	-4437.1	-3962.1	-3174.9	-2170.6	-1922	-1235.5	-1119.4	-1040.1	-1160.6	-796.8	-339.2	-348.1	-210.6	-209.7	-266.6	-222.6	-205	-264.1	-139.5	-141.5	-126.6	-78	-52.2
cash-flows.row.free-cash-flow	-1922.5	-1671.3	-1023.8	-1857.3	-739.6	-224.8	409.6	188.1	385.5	80.8	-28.4	-495.1	-480.2	-135.8	-86.2	22.4	-78.2	-81.7	-34.3	0.1	-113.9	-37	-73.4	11.8	-39.8	14.3

Kasumiaruande rida

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 2196.HK brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
income-statement-row.row.total-revenue	41399.5	43951.5	39005.1	30307	28585.2	24918.3	18533.6	14628.8	12608.6	12025.5	9996.4	7340.8	6485.5	4555.4	3872.3	3773.2	3693.3	3102	2988.5	2425.4	2154.6	1031.7	727.8	579.5	442.5	340.4	190.3	92.7	64.7
income-statement-row.row.cost-of-revenue	21595.3	23169.7	20228.3	13431.2	11543.4	10365.3	7609	6718.4	6308	6718.6	5543.4	4126.8	3991.1	2984.6	2610.7	2711.9	2693.8	2282.2	2076	1651.9	1564	668.1	448.9	307.6	248.4	209.3	116.5	65.3	50.1
income-statement-row.row.gross-profit	19804.2	20781.9	18776.8	16875.8	17041.7	14553	10924.6	7910.5	6300.6	5307	4453	3214	2494.4	1570.9	1261.6	1061.4	999.5	819.8	912.5	773.6	590.5	363.6	279	271.9	194	131.1	73.9	27.3	14.5
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-17.9	2683.7	2276.4	1841.5	1666	44.1	-13.2	181.9	78.3	324.6	97.9	89.9	158.8	62.1	56	30.9	21.9	60.5	96.5	52.8	42.7	18.1	12.3	18.9	10.9	8	10	-0.3	0.5
income-statement-row.row.operating-expenses	18240.9	17145	16055.8	14045.6	14425.7	12185.7	8621	6168.5	4827.1	4114.5	3339.1	2620.4	2149	1394.5	1098.2	939.7	834.5	794.6	829.5	658.2	549.4	304.1	206.9	172.3	102.3	62.6	31.6	14.3	4.9
income-statement-row.row.cost-and-expenses	39836.2	40314.7	36284.1	27476.8	25969.1	22551	16230	12886.8	11135.2	10833.1	8882.5	6747.2	6140.2	4379.1	3708.8	3651.6	3528.3	3076.7	2905.5	2310.1	2113.4	972.2	655.7	480	350.7	271.9	148.1	79.6	55
income-statement-row.row.interest-income	363.6	282.6	233.7	199.6	186.6	145.7	79.2	80.9	56.2	69.8	63.8	29.7	51.6	19.6	14.5	17.9	12.5	13.8	17.5	13.7	8.7	2.9	13.7	8.1	0	0	0	0	0
income-statement-row.row.interest-expense	1324.8	963.8	822.5	881	1074.7	929.7	577.5	488.2	470	415	350.5	370.6	314	162.4	132.4	149.6	130.6	83.3	72	37	45.9	36.2	23.7	9.8	-6.1	-3.3	3.1	3	1.5
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-42.9	-3722.2	-259.9	-43.3	-1887.5	1212.3	1758.1	1829.5	1898.4	1525.6	1792.3	1529.5	1381.3	1025.6	3101.2	714	591.4	249.1	124.7	159.4	282.5	104.1	76.8	42.6	12.8	5.2	-3.1	-3.1	-1.4
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-17.9	2683.7	2276.4	1841.5	1666	44.1	-13.2	181.9	78.3	324.6	97.9	89.9	158.8	62.1	56	30.9	21.9	60.5	96.5	52.8	42.7	18.1	12.3	18.9	10.9	8	10	-0.3	0.5
income-statement-row.row.total-operating-expenses	-42.9	-3722.2	-259.9	-43.3	-1887.5	1212.3	1758.1	1829.5	1898.4	1525.6	1792.3	1529.5	1381.3	1025.6	3101.2	714	591.4	249.1	124.7	159.4	282.5	104.1	76.8	42.6	12.8	5.2	-3.1	-3.1	-1.4
income-statement-row.row.interest-expense	1324.8	963.8	822.5	881	1074.7	929.7	577.5	488.2	470	415	350.5	370.6	314	162.4	132.4	149.6	130.6	83.3	72	37	45.9	36.2	23.7	9.8	-6.1	-3.3	3.1	3	1.5
income-statement-row.row.depreciation-and-amortization	2965.2	2335.9	2986.4	2171.8	1472.1	1320.1	938.6	732.9	649.3	558.4	415.5	286.2	209.9	152.7	134.7	132.5	136.5	132.1	116.7	91.1	56.1	37.6	28.6	28.1	20.1	9.3	-7	3.3	1
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	3307.5	8296.6	6313.7	4721.1	6413.2	3535.5	4074.9	3399.4	3297.2	2394.3	2818.8	2036	1580.5	1140.5	3212	807.6	736.7	347.1	234.5	298.2	329.4	168.5	144.1	141.9	106.3	77.3	49.3	9.8	8.7
income-statement-row.row.income-before-tax	3264.6	4574.4	6053.8	4677.8	4525.8	3579.6	4061.7	3571.5	3371.8	2718.1	2906.3	2123	1726.7	1202	3264.7	835.7	756.4	341	269.3	312.9	347.8	175.1	152.7	151.4	110.9	79.5	49.3	9.7	8.7
income-statement-row.row.income-tax-expense	369.5	626.9	1066.4	737.9	782.2	559.7	476.5	350.2	501.2	348.2	506.3	283.8	341.8	201.6	700.4	74.7	66.2	48.2	31.4	30.8	49.6	13.6	11.6	15.7	16.5	12.9	9.1	3.4	2.7
income-statement-row.row.net-income	2386.3	3730.8	4728.7	3662.8	3321.6	2707.9	3124.5	2805.8	2460.1	2112.9	2027.1	1563.9	1165.6	863.7	2498.2	690.9	625.8	259.2	159	215.3	263.6	147.2	135.5	128.5	92.2	63.7	36	6.4	6